Evoqua Water Technologies is upgrading its UK production facility for SeaCURE ballast water treatment systems ahead of new regulations for shipowners coming in September 2017.
Additionally, the US-based water treatment specialist is poised to introduce its next generation electrochlorination cell technology, which forms the core component of its dual-function SeaCURE ballast system.
“Roughly 4,000 vessels have been fitted with a treatment system to date, leaving about 30,000 vessels needing to retrofit within the next five years. Shipowners and yards need to plan ahead and to make sure that suppliers can deliver on time,” said Evoqua business manager, ballast water, Matt Granitto.
“While other suppliers are still proving their systems, we are optimising our electrochlorination-based water treatment system, and looking at standardising production,” added Granitto.
To prepare for an anticipated wave of orders ahead of the Ballast Water Management Convention rules coming into force in September 2017, Evoqua has honed its technology to reduce the system footprint.
The UK production facility investment covers a new compressed air system, dedicated welding bays and upgraded testing facilities, and component and assembly lines, and warehouse capacity, have been optimised.